An International Publisher for Academic and Scientific Journals
Author Login 
Scholars Journal of Applied Medical Sciences | Volume-8 | Issue-07
Changes of HRQoL in Patients of Pulmonary TB at Different Phases of Category-1 Anti-tubercular Chemotherapy
Dr. Md. Nazmul Hasan, Dr. Mohammed Mostanshir Billah, Dr. Md. Abdur Rahim, Dr. Imtiaz Ahmed, Dr. Md. Tariq Hasan
Published: July 4, 2020 | 163 120
DOI: 10.36347/sjams.2020.v08i07.004
Pages: 1656-1660
Downloads
Abstract
Background: Tuberculosis (TB) is the second common cause of death worldwide. Bangladesh is one of the high prevalent regions for tuberculosis. Tuberculosis significantly affects the quality of life of a patient. It not only affects the physical health but also alters the other domains like psychological aspect of health. Objective: In this study our main goal is to find out changes of HRQoL in patients of pulmonary TB at different phases of category-1 anti-tubercular treatment. Method: This cross-sectional study was conducted in Department of Internal Medicine, BSMMU, Dhaka from September, 2015 to September, 2016. About 61, respondents were included in the study. The HRQoL is assessed by SF-36 questionnaire which is already validated in Bengali beforehand. Results: Among 61patients, the average age of PTB patients mean (±SD) was (31±11.4) with a male preponderance. The improvement of HRQoL was significant (p<0.001) and continued till the end of treatment after six months. Comparison of the scores in patient before starting treatment and after the initial phase (first 2 months) of treatment shows significant improvement in all health domains (p<0.001). Also, there is a significant difference of HRQoL score between pulmonary tuberculosis patient at two months of treatment and completion of anti-tubercular chemotherapy (p<0.001). Conclusion: This study observed that HRQoL improves significantly with DOTS-based anti-tubercular treatment. Therefore, quality of life in addition to chemotherapy should be taken into account in case of tuberculosis treatment.